R&D

SAFA is expandable to
diverse pipelines

  • home
  • R&D
  • Pipelines

PIPELINE

Pipeline Indication Target Screening Discovery Pre-clinical Clinical Stage
Self-developed L/O
Autoimmune CD40L
Phase 1
Partner: Lundbeck
Autoinflammastory 1L-18
Phase 1
Started March 2023
Autoimmune 1L-2R
PRE-CLINICAL
Toxicity
Solid Cancer XX
-
Solid Cancer XX
-
Solid Cancer XX
-
Obesity GLP-1R
-
Co-developed Male Infertility FSHR
Co-study with Severance Hospital
Partner : Severance
Hospital
Endocrine TSHR
Co-study with Severance Hospital
Partner : Severance
Hospital
L/O
Solid Cancer XX
SCREENING
Partner: Yuhan